<!DOCTYPE HTML>
<html lang="en">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Shahmir Aziz</title>

    <meta name="author" content="Shahmir Aziz">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="shortcut icon" href="images/headshot.png" type="image/x-icon">
    <link rel="stylesheet" type="text/css" href="stylesheet.css">
  </head>

  <body>
    <table style="width:100%;max-width:800px;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
      <tr style="padding:0px">
        <td style="padding:0px">
          <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
            <tr style="padding:0px">
              <td style="padding:2.5%;width:63%;vertical-align:top">
                <p class="name" style="text-align: left;">
                  Shahmir Aziz
                </p>

                <p class="bio">
                  I am a Rhodes Scholar DPhil student at Oxford's <a href="https://www.kavli.ox.ac.uk">Kavli Institute for Nanoscience Discovery</a>,
                  working with <a href="https://www.bioch.ox.ac.uk/research/robinson">Dr. Dame Carol Robinson</a> on machine learning for nanoscale robotics.
                </p>

                <p class="bio">
                  Previously, I graduated from Harvard AB Summa Cum Laude in Mathematics and Biomedical Engineering with a minor in Computer Science.
                  I was awarded the John Harvard Scholar designation and the Detur Prize, the oldest academic prize at Harvard.
                </p>

                <p class="bio">
                  I've done quantitative research at Citi's rates trading desk,
                  biological systems optimization at Novo Nordisk, and co-founded SAR Capital Management,
                  an intercollegiate hedge fund focused on biotech equities where I lead quantitative research.
                </p>

                <p class="bio">
                  My research interests lie at the intersection of machine learning and nanoscale robotics,
                  particularly in developing ML algorithms for controlling swarm behavior at the molecular level,
                  optimizing targeted drug delivery systems, and creating autonomous nanoscale surgical tools.
                </p>

                <p style="text-align:left; margin-top: 20px;">
                  <a href="mailto:shahmiraziz@college.harvard.edu">Email</a> &nbsp;/&nbsp;
                  <a href="https://www.linkedin.com/in/shahmiraziz/">LinkedIn</a>
                </p>
              </td>
              <td style="padding:2.5%;width:37%;max-width:37%;vertical-align:top">
                <a href="images/headshot.png"><img style="width:100%;max-width:100%;object-fit: cover; border-radius: 50%;" alt="profile photo" src="images/headshot.png" class="hoverZoomLink"></a>
              </td>
            </tr>
          </tbody></table>


    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Publications</h2></td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/publication.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <p> <a href="shahmir_thesis.pdf">Engineering Asymmetric Nanoscale Lipid Vesicles for Uptake-Optimized Drug Delivery</a><br>
          <em><strong>Harvard Senior Thesis</strong></em> | <em>bioRxiv Preprint</em></p>
        <p><strong>Shahmir Aziz</strong>, David Mooney, David Weitz<br>
          <em>Harvard College & bioRxiv</em>, 2025<br>
          <a href="shahmir_thesis.pdf">thesis</a> /
          <a href="Engineering asymmetric nanoscale lipid vesicles for drug delivery | bioRxiv.html">bioRxiv</a></p>
        <p>Engineered asymmetric lipid vesicles with tunable membrane curvature achieving 3.7× enhanced cellular uptake. Demonstrated shape-dependent endocytosis pathways using super-resolution microscopy and developed scalable microfluidic fabrication yielding 10^9 vesicles/hour.</p>
      </td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Research Projects</h2></td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/soma.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <p class="papertitle">Self-Orienting Millimeter-scale Applicators (SOMA) for Oral Insulin Delivery</p>
        <p style="font-size:14px;color:#666;">Novo Nordisk Collaboration</p>
        <p>Developing ingestible devices that autonomously orient and inject insulin through gastric tissue. Achieved 30% bioavailability in porcine models vs 0.5% for conventional oral formulations. Currently optimizing spring-loaded mechanism for consistent 7N deployment force.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/glucose.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <p class="papertitle">ML-Driven Glucose Prediction During Exercise in Type 1 Diabetes</p>
        <p style="font-size:14px;color:#666;">T1DEXI Dataset Analysis - Doyle Group</p>
        <p>Analyzed 256 adults' CGM data during 50,000+ exercise sessions. Built transformer model predicting hypoglycemic events 45 minutes in advance with 89% sensitivity. Discovered resistance training causes 60% less glucose variability than aerobic exercise. <a href="Research Presentation v3- EMA 2.pdf">presentation</a></p>
      </td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/microbot.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <p class="papertitle">Magnetic Control of Microscale Surgical Robots</p>
        <p style="font-size:14px;color:#666;">Harvard Micro Robotics Lab</p>
        <p>Designed control algorithms for 500μm untethered robots navigating vascular networks. Implemented real-time path planning achieving 95% navigation success in 3D-printed arterial phantoms. Developing swarm coordination for multi-robot procedures.</p>
      </td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Blog Posts</h2></td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/blog1.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <a href="blog1.html">
          <span class="papertitle">Engineering Log: Stochastic Gradient Descent for Molecular Swarm Control</span>
        </a>
        <br>
        <em>Week 14 - December 2024</em>
        <br>
        <p>85% complete. RL approach for 10^4 particle swarm control. Current bottleneck: gradient explosion at t>1000. Real-world success: 71% (up from 61%). Targeting animal trials Week 17.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/blog2.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <a href="blog2.html">
          <span class="papertitle">Research Notes: Transformer Networks for Protein-Nanoparticle Binding</span>
        </a>
        <br>
        <em>Week 11 - November 2024</em>
        <br>
        <p>R²=0.79 but fails on glycosylated proteins. 14ms inference vs 48hr simulations. Working on uncertainty quantification. Code too messy to release yet.</p>
      </td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Experience</h2></td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Co-Founder</strong> - SAR Capital Management</p>
        <p class="experience-date">November 2023 - Present</p>
        <p>Co-founded intercollegiate hedge fund focused on biotech equities. Built ML pipeline analyzing clinical trial outcomes, patent filings, and FDA communications. Portfolio up 47% YTD focusing on nanomedicine and cell therapy companies.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Mathematics Teaching Fellow</strong> - Harvard University</p>
        <p class="experience-date">August 2022 - Present</p>
        <p>Tutored students in Math courses on multivariable calculus and linear algebra. Worked with professors to employ interactive teaching methods.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Quant Trading / Research Intern</strong> - Citi</p>
        <p class="experience-date">May 2024 - August 2024</p>
        <p>Developed yield curve arbitrage strategies using PCA on historical rate movements. Built real-time P&L attribution system processing 100k+ trades daily. Strategies generated $2.3M alpha during summer rotation.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Biological Systems Analyst</strong> - Novo Nordisk</p>
        <p class="experience-date">May 2023 - August 2023</p>
        <p>Optimized insulin production yields using Bayesian optimization on 47 process parameters. Reduced batch failure rate by 31% through predictive quality models. Worked on SOMA device prototyping for oral insulin delivery.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Executive Board - Chief Auditor</strong> - Harvard International Relations Council</p>
        <p class="experience-date">April 2022 - June 2023</p>
        <p>In charge of $1M budget of Harvard's largest student-run organization. Head finances and executive dealings of umbrella organization presiding over all International Relations-affiliated groups on campus.</p>
      </td>
    </tr>
    </tbody></table>

          <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
            <tr>
              <td style="padding:0px">
                <br>
                <p style="text-align:right;font-size:small;">

                </p>
              </td>
            </tr>
          </tbody></table>
        </td>
      </tr>
    </table>

  </body>
</html>